Sunshine Biopharma
SBFM
5 hedge funds and large institutions have $292K invested in Sunshine Biopharma in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
12% more capital invested
Capital invested by funds: $262K → $292K (+$30.8K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$18.2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$8.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $200K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $28.2K | – | – | – |
|
|
VF
3
Virtu Financial
New York
| $20K | -$18.2K | -1 | -50% |
|
|
TSS
4
Two Sigma Securities
New York
| $18.5K | +$18.2K | +1 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $14.1K | – | – | – |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $4.84K | – | – | – |
|
7
National Bank of Canada
Montreal,
Quebec, Canada
| $4.23K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $1.76K | – | – | – |
|
|
NECFA
9
New England Capital Financial Advisors
Meriden,
Connecticut
| $366 | – | – | – |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $58 | – | – | – |
|
11
Morgan Stanley
New York
| $19 | – | – | – |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | -$8.88K | -1 | Closed |
|
SBFM Hedge Fund Activity: Q1 2023 in Review
5 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q1 2023, worth a combined $292K — up 12% from $262K a quarter earlier.
Fund positioning in SBFM was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $18.2K. The largest seller was Virtu Financial, cutting an estimated $18.2K.
- 5 institutional investors held Sunshine Biopharma (SBFM) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $292K of Sunshine Biopharma stock for Q1 2023, up 12% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest Sunshine Biopharma buyer in Q1 2023 was Two Sigma Securities, an estimated $18.2K added.
- The largest Sunshine Biopharma seller in Q1 2023 was Virtu Financial, an estimated $18.2K sold.
Based on aggregated 13F filings for Q1 2023.